Ovid Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
4.50
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
3
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.21
|
-0.17
|
0.04
|
19.05%
|
|
2022-06-30
|
-0.25
|
-0.21
|
0.04
|
16.00%
|
|
2022-03-31
|
-0.21
|
-0.23
|
-0.02
|
-9.52%
|
|
2021-12-31
|
-0.16
|
-0.10
|
0.06
|
37.50%
|
|
2021-09-30
|
-0.18
|
-0.17
|
0.01
|
5.56%
|
|
2021-06-30
|
-0.16
|
-0.23
|
-0.07
|
-43.75%
|
|
2021-03-31
|
1.68
|
2.53
|
0.85
|
50.60%
|
|
2020-12-31
|
-0.31
|
-0.34
|
-0.03
|
-9.68%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.61
|
|
2021-12-31
|
2.03
|
|
2020-12-31
|
-1.40
|
|
2019-12-31
|
-1.58
|
|
2018-12-31
|
-2.12
|
|
2017-12-31
|
-4.88
|